Menu

Henry Schein at a Glance

Investor Overview

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Henry Schein Appoints Dr. Margaret Hamburg to Board of Directors
    MELVILLE, N.Y.--(BUSINESS WIRE)--Nov. 3, 2003--

         New Board Member Held Health Policy Positions in the
  Administrations of Presidents Clinton and Reagan, and New York City
                      Mayors Giuliani and Dinkins

Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets, today announced the appointment of Margaret A. Hamburg, M.D. to its Board of Directors. Dr. Hamburg has over 15 years of public health experience, holding policy positions in both the Clinton and Reagan administrations, as well as the Giuliani and Dinkins administrations in New York City.

"Dr. Hamburg is a wonderful addition to the Henry Schein Board of Directors," said Stanley M. Bergman, Chairman, Chief Executive Officer, and President of Henry Schein. "Her experience at every stage of her career -- as a practicing physician, as chief health officer in the nation's largest city, and as someone who has shaped health policy for the entire nation -- will be invaluable to our company, and our Board and management team look forward to the many insights that Dr. Hamburg will provide. Dr. Hamburg's expertise and counsel will be an important asset as we continue to build on Henry Schein's success and growth into the future."

"Henry Schein reaches the practices of hundreds of thousands of physicians, dentists, and other heath care providers, and touches the lives of millions of patients around the world," said Dr. Hamburg. "Given the scope of products and services offered by the company, which include vaccines, pharmaceuticals, and emergency medical response supplies, the role that Henry Schein plays in safeguarding our nation's health will only become more important in the years to come. It is a pleasure to be joining Henry Schein's Board, and I look forward to helping the company leverage many opportunities in the future."

About Dr. Hamburg

Dr. Hamburg held the position of Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, serving as principal policy advisor to Secretary of Health and Human Services Donna E. Shalala from 1997 to 2001. Her responsibilities included policy formulation and analysis, the development and review of regulations and legislation, budget analysis, strategic planning, and the conduct and coordination of policy research and program evaluation.

In addition, Dr. Hamburg served as the Commissioner of Health for the City of New York from 1991 to 1997. In this position, she designed and implemented an internationally recognized tuberculosis control program that produced dramatic declines in tuberculosis cases, developed initiatives that raised childhood immunization rates to record levels, and created the first public health bio-terrorism preparedness program in the nation. Dr. Hamburg was Special Assistant to the Director, and later Assistant Director of the National Institute of Allergy & Infectious Diseases at the National Institutes of Health from 1988-1990. Before that, she was Special Assistant to the Director, Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services from 1986-1988.

Born in Chicago, Ill., Dr. Hamburg is a graduate of Harvard College and Harvard Medical School, and currently serves on the Harvard College Board of Overseers. She completed her internship and residency in internal medicine at the New York Hospital/Cornell University Medical Center, and is certified by the American Board of Internal Medicine. Dr. Hamburg has been elected to membership in the Institute of Medicine, the New York Academy of Medicine, the Council of Foreign Relations, and is a Fellow of the American Association for the Advancement of Science and the American College of Physicians.

Throughout her career, Dr. Hamburg has received numerous awards and distinctions, and presently is a member of 19 boards and committees dealing with a wide variety of health, security, public policy, and educational issues, with a focus on national policy and response to various emergencies. In addition, she currently is a Distinguished Senior Fellow of the Center for Strategic & International Studies in Washington, D.C. Dr. Hamburg has 34 publications and four abstracts in a wide range of professional journals, including The New England Journal of Medicine and The Lancet. In addition she has authored many articles for general audiences, which have appeared in the Washington Post, New York Daily News, New York Newsday, and other publications.

About Henry Schein

Recognized for its excellent customer service and low prices, Henry Schein serves more than 400,000 customers worldwide, including dental practices and laboratories, physician practices and veterinary clinics, as well as government and other institutions.

The Company operates its four business groups - Dental, Medical, International and Technology through a centralized and automated distribution network, which provides customers in more than 125 countries with a comprehensive selection of over 90,000 national and Henry Schein private-brand products. Henry Schein also offers a wide range of innovative value-added practice solutions, including such leading practice management software systems as DENTRIX(R) and Easy Dental(R) for dental practices, and AVImark(R) for veterinary clinics, which are installed in over 50,000 practices; and ArubA(R), Henry Schein's electronic catalog and ordering system.

Headquartered in Melville, New York, Henry Schein employs over 7,000 people in 16 countries. The Company's 2002 sales reached a record $2.8 billion. For more information, visit the Henry Schein Web site at www.henryschein.com.

Certain information contained herein includes information that is forward-looking. The matters referred to in forward-looking statements may be affected by the risks and uncertainties involved in the Company's business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in the Company's Securities and Exchange Commission filings.

Note: A photo is available at URL:

http://www.businesswire.com/cgi-bin/photo.cgi?pw.110303/bb1


    CONTACT: Henry Schein, Inc.
             Steven Paladino, 631-843-5500
              or
             Manager, Investor and
             Public Relations:
             Susan Vassallo, 631-843-5562
             svassa@henryschein.com

    SOURCE: Henry Schein, Inc.